{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:42:51Z","timestamp":1786236171331,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179090","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:17:13Z","timestamp":1782343033000},"page":"179090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Attenuated Salmonella typhimurium L-forms combined with lentiviral shRNA-HOTAIR suppress tumorigenicity and aggressiveness of murine breast cancer by inhibiting EGFR\/Snail\/MMP9 pathway"],"prefix":"10.1016","volume":"1030","author":[{"given":"Ziqing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-5521","authenticated-orcid":false,"given":"Dengyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2026.179090_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","article-title":"Metabolomic rewiring promotes endocrine therapy resistance in breast cancer","volume":"84","author":"Ahn","year":"2024","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179090_bib2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cancers12051197","article-title":"Long non-coding RNA HOTAIR in breast cancer therapy","volume":"12","author":"Cantile","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179090_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114295","article-title":"Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy","volume":"185","author":"Chen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.ejphar.2026.179090_bib4","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1158\/1078-0432.CCR-23-3110","article-title":"Anti-EGFR antibody-drug conjugate carrying an inhibitor targeting CDK restricts triple-negative breast cancer growth","volume":"30","author":"Cheung","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.ejphar.2026.179090_bib5","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179090_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/2211-5463.13415","article-title":"Ets family proteins regulate the EMT transcription factors Snail and ZEB in cancer cells","volume":"12","author":"Ichikawa","year":"2022","journal-title":"FEBS Open Bio"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179090_bib8","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050193","article-title":"HOTAIR lncRNA promotes epithelial-mesenchymal transition by redistributing LSD1 at regulatory chromatin regions","volume":"22","author":"Jarroux","year":"2021","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12943-024-02150-4","article-title":"Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR","volume":"23","author":"Kang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54920-9","article-title":"The dysadherin\/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179090_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177962","article-title":"A novel recombinant attenuated Salmonella carrying RGD and melittin genes induces apoptosis of B16 cells and inhibits melanoma growth","volume":"1003","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179090_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","article-title":"Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer","volume":"161","author":"Li","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2026.179090_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2019.01.037","article-title":"Genetically engineered Salmonella Typhimurium: recent advances in cancer therapy","volume":"448","author":"Liang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2026.179090_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122951","article-title":"Engineered VNP20009 expressing IL-15&15Ralpha augments anti-tumor immunity for bladder cancer treatment","volume":"315","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179090_bib16","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/cells10092202","article-title":"Snail upregulates transcription of FN, LEF, COX2, and COL1A1 in hepatocellular carcinoma: a general model established for snail to transactivate mesenchymal genes","volume":"10","author":"Ly","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179090_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clbc.2024.03.001","article-title":"The role of immunotherapy in triple-negative breast cancer (TNBC)","volume":"24","author":"Michaels","year":"2024","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12935-024-03612-x","article-title":"HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives","volume":"24","author":"Nazari","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-023-01765-3","article-title":"HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer","volume":"22","author":"Raju","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2026.179090_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lungcan.2020.06.037","article-title":"HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib21","article-title":"Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer","volume":"7","author":"Xi","year":"2026","journal-title":"Cell Rep. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179090_bib6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41418-022-00940-1","article-title":"IKBKE phosphorylates and stabilizes Snail to promote breast cancer invasion and metastasis","volume":"29","author":"Xie","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179090_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122960","article-title":"A positive-feedback loop suppresses TNBC tumour growth by remodeling tumour immune microenvironment and inducing ferroptosis","volume":"315","author":"Ye","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib24","article-title":"Attenuated Salmonella typhimurium L forms suppress tumor growth and promote apoptosis in murine ovarian tumors","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179090_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178109","article-title":"Attenuated Salmonella typhimurium L forms combined with lentivirus shRNA-HOTAIR effectively inhibit tumor growth and metastasis in murine epithelial ovarian cancer","volume":"1005","author":"Zhang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179090_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41420-022-01174-3","article-title":"Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance","volume":"8","author":"Zhu","year":"2022","journal-title":"Cell Death Discov."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:22:41Z","timestamp":1786234961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S0014299926005728"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179090","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuated Salmonella typhimurium L-forms combined with lentiviral shRNA-HOTAIR suppress tumorigenicity and aggressiveness of murine breast cancer by inhibiting EGFR\/Snail\/MMP9 pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179090"}}